ALK and anaplastic large cell lymphoma: Patients with ALK+ S-ALCL were significantly younger than those with ALK- S-ALCL (median age 22 vs. 30 years) (P<0.05), but both subgroups had a predominance of males, and a similar proportion of stage III/IV disease (ALK+ 49%; ALK- 51%).